Here, we investigated the gene expression of RAS components (ATP6AP2, AGTR1, AGTR2, ACE, AGT, and REN) in glioblastoma patient samples from The Cancer Genome Atlas (TCGA) and their association with survival outcomes and the expression of TME pathways. This evidence concerns the gene AGTR1 and glioblastoma.